Transforming Agriculture with Microbial Innovation for Sustainable Growth
Dr. Paul Rutten is the CEO and Founder of Concert Bio, a pioneering biotech company focused on restoring missing microbes in greenhouse and soilless farming systems. With a PhD in plant-microbe interactions from the University of Oxford, Paul has leveraged his deep expertise to create Overture™, Concert Bio’s flagship product. This product has led to average yield improvements of almost ten percent in 2024. His global background and passion for agricultural innovation drive his commitment to transforming food production systems worldwide.
Concert Bio – Unlocking the Power of Microbes for Better Yields
Concert Bio revolutionizes agriculture by restoring critical microbes to greenhouse and soilless farming systems. Through Overture™, their first beneficial microbe product, Concert Bio is enhancing plant growth, boosting yields, and improving sustainability. With the most extensive controlled-environment agriculture (CEA) plant-microbe data database, the company partners with US, UK, and EU growers to optimize production. With a proven track record of increasing yields by nearly 10%, Concert Bio is reshaping the future of farming with science-driven solutions that support both productivity and sustainability.
